Closed
NONE
RFP - 2-PAM Autoinjectors for Project Bioshield (PBS)
- NAICS
- 541714
- Place of performance
- Washington, DC
- Closed
- Jul 29, 2026
- Posted
- Jul 8, 2026
Description
BARDA seeks late-stage clinical development, regulatory approval for 2-PAM autoinjectors (as a drug/device combination product) to treat organophosphate (OP) poisoning, including nerve agents, in adult and pediatric populations, and procurement of 2-PAM autoinjectors for the SNS/CHEMPACK Program.
Track this market for the recompete
This opportunity has closed. Follow NAICS 541714 and we'll alert you when the follow-on contract posts.